Condition deep-dive · 7 min read

Fibromyalgia supplement protocol — what has trial evidence

Updated 2026-05-10 · Reviewed by SupplementScore editors · No sponsorships

Fibromyalgia is a clinical syndrome of widespread pain, fatigue, sleep disruption, and cognitive complaints — central sensitisation rather than peripheral tissue damage. Standard care includes graded exercise, CBT, and selected pharmacotherapy (duloxetine, milnacipran, pregabalin); supplements are adjuncts to that base, not substitutes. The trial evidence is most consistent for vitamin D in deficient patients, magnesium, CoQ10, and SAMe — with everything else in the "smaller signals, more cautious interpretation" bucket.

Read this first. Fibromyalgia is a clinical diagnosis that requires ruling out treatable mimics (hypothyroidism, vitamin D deficiency, vitamin B12 deficiency, sleep apnoea, polymyalgia rheumatica, inflammatory arthritides, depression with somatic features). Don't anchor on a "supplement protocol" before that workup. Several supplements below interact with central pain medications; coordinate with your prescriber.

What actually has trial evidence

Tier 1 evidence · Pain in vitamin D-deficient patients

Vitamin D3 (in confirmed deficiency)

2,000–4,000 IU/day; target 25-OH-D 30–50 ng/mL after 12 weeks

Vitamin D deficiency is more common in fibromyalgia cohorts than in matched controls, and correction of deficiency has shown reductions in pain scores and improved function in multiple small RCTs. The catch is that supplementation in non-deficient patients does not appear to add benefit. Test 25-OH-D first; supplement to a target. The Wepner 2014 trial showed reductions in pain and improvement in function over 24 weeks of correction.

Tier 2 evidence · Tender point pain + sleep

Magnesium (glycinate or malate)

300–500 mg elemental magnesium evenings, ≥8 weeks

Several small RCTs in fibromyalgia have shown improvement in tender point counts, pain scores, and sleep quality with magnesium supplementation, sometimes combined with malic acid (the "magnesium malate" combination). Effect sizes are modest. Glycinate form is well-tolerated and adds the mild sleep benefit of glycine itself. Avoid in advanced kidney disease.

Tier 2 evidence · Pain and fatigue

CoQ10 (Ubiquinone or Ubiquinol)

100–300 mg/day with the largest meal, ≥8 weeks

Mitochondrial dysfunction has been described in fibromyalgia muscle biopsies, and CoQ10 supplementation at 300 mg/day has shown reductions in pain, fatigue, and tender points in small RCTs (Cordero 2013; Miyamae 2013 in juvenile-onset fibromyalgia). Effect builds over 8–12 weeks. Take with a fat-containing meal — ubiquinone is lipid-soluble. Discuss with prescriber if on warfarin.

Tier 2 evidence · Pain + mood (older trials)

SAMe (S-Adenosyl methionine)

800 mg/day enteric-coated, split into two doses

Older but reasonably consistent RCT data (Jacobsen 1991; Tavoni 1987) for SAMe in fibromyalgia, showing reductions in tender points, pain at rest, and depressive symptoms. Effect builds over 4–8 weeks. The expense and the GI tolerability of older preparations was a barrier; modern enteric-coated forms have improved both. Discuss with prescriber if on serotonergic antidepressants — additive serotonergic effects are a theoretical concern.

The sleep and mood layer

Sleep disruption drives fibromyalgia pain perception, so the sleep-supportive layer is meaningful here:

Magnesium glycinate 300–400 mg evenings — covered above; addresses both sleep and pain dimensions.
Glycine 3 g at bedtime — useful for sleep maintenance; small but supportive evidence.
L-Theanine 200 mg at bedtime — for the racing-mind sleep onset pattern often present.
Saffron (Crocus sativus) 30 mg/day — emerging mood-supportive evidence; reasonable adjunct in users with co-occurring depressive symptoms.

The exercise + nutrient repletion base

The supplement intervention with the strongest evidence in fibromyalgia is graded aerobic exercise — that's not a supplement, but no supplement protocol works without it. On top of that:

Vitamin B12 if low — common in older patients and in chronic PPI users; methylcobalamin sublingual or IM injection per primary care.
Iron if ferritin < 50 — the lower-end-of-normal ferritin range can drive fatigue and restless legs symptoms common in fibromyalgia.
Vitamin D3 to target as discussed above.

What to skip

"Adrenal support" formulas — fibromyalgia is not adrenal failure, the "adrenal fatigue" framing is not supported, and these formulas often contain stimulants and animal-tissue extracts of dubious composition.
Mega-dose multivitamins / IV vitamin therapy — no demonstrated benefit specific to fibromyalgia; risk of vitamin toxicity (particularly iron and fat-soluble vitamins) over time.
Standalone 5-HTP at high doses — small positive trials exist but the eosinophilia-myalgia syndrome history and serotonin syndrome risk in patients on SSRIs/SNRIs make it a poor fit for the most common care plans.
"Mitochondrial support" combination products with sub-therapeutic CoQ10 + PQQ + NMN — pay for standardised CoQ10 at the trial dose instead.
CBD products marketed for fibromyalgia — limited fibromyalgia-specific RCT evidence, highly variable product composition, and meaningful drug-interaction footprint with central nervous system medications.

What to track

Pick 2–3 clinically meaningful endpoints rather than everything. Common choices: average daily pain (0–10 NRS), Fibromyalgia Impact Questionnaire (FIQR) score, sleep quality (PSQI), and a function metric (steps per day, time to morning stiffness resolution). Reassess at 8 and 16 weeks. A 30%+ reduction in baseline pain is clinically meaningful; smaller reductions are within placebo/noise range.

Practical quick-start. Test 25-OH-D, B12, ferritin, and TSH first. Correct any deficiencies. Then: magnesium glycinate 300 mg evenings + CoQ10 200 mg with the largest meal + (if vitamin D was deficient) D3 to target. Pair with a graded exercise programme and your standard care plan. Reassess at 12 weeks before adding more.